| ||||||||||||||||||||||||||||||||||||||||||||||||
Institute for Experimental and Clinical Pharmacology and Toxicology, University Erlangen-Nuremberg, Nuremberg, Germany
Response to Letter by Tsuda
Renke Maas MD;
Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
The National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Mass, and Department of Neurology, School of Medicine, Boston University, Boston, Mass
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |